Expression of tumor suppressor gene PAQR3 in lung cancer was decreased

[1]

HUANG Qianqian, JIA Yufang, YU Huajun,CHEN Rongrong,CHEN Lili, WU Jun, ZHANG Haitao. Stable knockout of ACSS3 in lung cancer cell line using CRISPR/Cas 9 technology [J]. Basic & Clinical Medicine, 2025, 45(8): 1016-1021.

[2]

[3]

YANG Rui, DU Sifen, JIANG Lehui, FU Tian, REN Pengju, JIANG Chengyu, ZHANG Yanli. Network pharmacology-based screening and validation of tea-derived small molecules against lung cancer [J]. Basic & Clinical Medicine, 2025, 45(7): 939-946.

[4]

LOU Haijun, TONG Zhuoyun, ZHANG Zhenyu, Aheyerk·MAHESHATI, MENG·Menggen, WUDU Muli. Knockdown of DRAM2 inhibits the proliferation and migration of lung cancer cell line A549 [J]. Basic & Clinical Medicine, 2025, 45(2): 197-202.

[5]

ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan. Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549 [J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.

[6]

CAO Chenxin, TANG Hui, GENG Ruixuan, GUO Fuping, BAI Chunmei, WANG Yingyi, LI Taisheng. Correlation between circulating CD4⁺CD45RA⁺CD62L⁺ T cells and prognosis of metastatic non-small cell lung cancer treated with EGFR-TKI [J]. Basic & Clinical Medicine, 2024, 44(5): 658-664.

[7]

[8]

ZHANG Jing, YANG Zigeng, CAI Wenqin, CAO Weiwei, WEI Hongmei, XUE Xixi, WU Bin. Inhibition of prohibitin 2 enhances the sensitivity of non-small cell lung cancer cell line A549 to erlotinib [J]. Basic & Clinical Medicine, 2024, 44(3): 325-332.

[9]

[10]

[11]

JIA Kun, ZHOU Yanyan. MYC inhibits migration of lung cancer cell lines by down-regulating AKR1C1 expression [J]. Basic & Clinical Medicine, 2024, 44(12): 1621-1627.

[12]

[13]

YAN Chenhong, JIN Er. Progress of exosomal PD-L1 in diagnosis and treatment of non-small cell lung cancer [J]. Basic & Clinical Medicine, 2023, 43(9): 1457-1461.

[14]

ZHANG Xiaowan, KANG Xia, YAO Xiaoying, XIE Fang, LI Ying. Silencing SF3B1 promotes apoptosis and inhibits proliferation and invasion of human lung cancer cell line A549 [J]. Basic & Clinical Medicine, 2023, 43(8): 1265-1270.

[15]

LI Zhen, DUAN Zhaojun, LUO Yunping. Ganglioside GD2 is a potential candidate marker for lung cancer stem cells [J]. Basic & Clinical Medicine, 2023, 43(5): 777-784.

PDF